{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:23:01Z","timestamp":1791868981489,"version":"4.3.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104004","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T21:13:53Z","timestamp":1406841233000},"page":"e104004","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Clinical Features, Treatment and Outcome of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Ocular Adnexa: Single Center Experience of 60 Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Barbara","family":"Kiesewetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kuchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius E.","family":"Mayerhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heimo","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"W\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"ref1","first-page":"1430","article-title":"Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology","volume":"105","author":"SE Couland","year":"1998"},{"key":"ref2","first-page":"907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"C Jenkins","year":"2000","journal-title":"Br J Ophtlamology. 2000"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: A study of 353 cases","volume":"31","author":"JA Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"ref4","unstructured":"Isaacson PG, Chott A, Nakumura S, M\u00fcller-Hermelink HK, Harris NL, <etal>et al<\/etal>. (2008) Extranodal marginal cell lymphoma of mucosa-associated tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. WHO classification of tumours of the haematopoietic and lymphoid tissues. IARC: Lyon, France. 214\u2013219."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","article-title":"The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori","volume":"342","author":"T Hussell","year":"1993","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.leu.2404782","article-title":"MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course","volume":"21","author":"S W\u00f6hrer","year":"2007","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"KE Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"AJ Ferreri","year":"2004","journal-title":"J Natl Cancer Inst 2004"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"E Chadunet","year":"2006","journal-title":"J Pathol"},{"key":"ref10","first-page":"747","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut","volume":"60","author":"A Ruskon\u00e9-Fourmestraux","year":"2011"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00277-012-1469-3","article-title":"Ophthalmologic outcomes after chemotherapy and\/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma","volume":"91","author":"JS Paik","year":"2012","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"A Stefanovic","year":"2009","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients","volume":"59","author":"SH Lim","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in in one third of 158 patients analyzed","volume":"95","author":"C Thieblemont","year":"2000","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","article-title":"Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma","volume":"19","author":"EK Song","year":"2008","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","article-title":"Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit","volume":"113","author":"GJ Ben Simon","year":"2006","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.2012.072587","article-title":"Rituximab plus subcutaneous cladribine in patients with extranodal marginal-zone B-cell lymphoma of the mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie","volume":"98","author":"M Troch","year":"2013","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"A Conconi","year":"2003","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2012.065995","article-title":"A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated tissue (MALT lymphoma)","volume":"98","author":"B Kiesewetter","year":"2013","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/10428194.2010.534519","article-title":"90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa-associated lymphoid tissue lymphoma","volume":"52","author":"M Hoffmann","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","article-title":"Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnxeal lymphoma","volume":"20","author":"B Esmaeli","year":"2009","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","article-title":"Long-term follow up results of no initial therapy for ocular adnxeal MALT lymphoma","volume":"17","author":"K Tanimoto","year":"2006","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila Psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"AJ Ferreri","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2141.2010.08179.x","article-title":"Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial","volume":"150","author":"S Govi","year":"2010","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1349-7006.2010.01502.x","article-title":"First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors","volume":"101","author":"TM Kim","year":"2010","journal-title":"Cancer Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/annonc\/mdm561","article-title":"Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma","volume":"19","author":"AJ Ferreri","year":"2008","journal-title":"Ann Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial","volume":"98","author":"AJ Ferreri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1054\/bjoc.2000.1308","article-title":"Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma","volume":"83","author":"M Raderer","year":"2000","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.eye.6702027","article-title":"Thyroid orbitopathy predisposes to late onset of periocular lymphoma","volume":"20","author":"CM Nutting","year":"2006","journal-title":"Eye (Lond.)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428199909058411","article-title":"Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnxeal lymphoma","volume":"32","author":"M Nakata","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","article-title":"Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathological review according to the WHO classification","volume":"57","author":"M Hasegawa","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1442-9071.2001.d01-18.x","article-title":"Ocular adnexal lymphoproliferative disease: a series of 73 cases","volume":"29","author":"PA McKelvie","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"RW Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"T Uno","year":"2003","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijrobp.2009.04.018","article-title":"Primary radiation therapy in patients with localized orbital marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lLmphoma)","volume":"77","author":"SH Son","year":"2010","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"N Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomized, phase 3 non-inferiority trial","volume":"381","author":"MJ Rummel","year":"2013","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"M Raderer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","article-title":"Antibiotic therapy in non-gastrointestinal MALT lymphoma: a review of the literature","volume":"122","author":"B Kiesewetter","year":"2013","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:57:37Z","timestamp":1717181857000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104004"}},"subtitle":[],"editor":[{"given":"Apar Kishor","family":"Ganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104004","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}